TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group.
about
Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapyHuman papilloma virus infection in head and neck cancerEnhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial.Quantitative tool to evaluate the somatic burden due to chemotherapy-induced adverse events: the somatic burden score.Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer.[Multimodal laryngeal preservation: current data-based opinion].Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trialsUpdate on De-intensification and Intensification Studies in HPV.Toxicity burden score: a novel approach to summarize multiple toxic effects.Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach.Use and misuse of common terminology criteria for adverse events in cancer clinical trials.The changing landscape of oropharyngeal cancer management.Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical TrialsLongitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254Adoption of transoral robotic surgery compared with other surgical modalities for treatment of oropharyngeal squamous cell carcinoma.The use of and adherence to CTCAE v3.0 in cancer clinical trial publications.Current concepts of organ preservation in head and neck cancer.Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review.Hazards and risks in oncology: radiation oncology.Functional outcomes after TORS for oropharyngeal cancer: a systematic reviewOutcomes in Advanced Head and Neck Cancer Treated with Up-front Neck Dissection prior to (Chemo)Radiotherapy.The Cisplatin Total Dose and Concomitant Radiation in Locoregionally Advanced Head and Neck Cancer: Any Recent Evidence for Dose Efficacy?Safety of drug treatments for head and neck cancer.Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer.Treatment de-intensification strategies for head and neck cancer.Complications, hospital length of stay, and readmission after total laryngectomy.Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial.The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer.Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma.Patient preferences for oropharyngeal cancer treatment de-escalation.Facing head and neck cancer deaths head on: lessons for survival.Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.Estimating global treatment toxicity burden from adverse-event data.Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.Voice outcomes after concurrent chemoradiotherapy for advanced nonlaryngeal head and neck cancer: a prospective study.Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review.Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer.Changing the perspective: current trends in the assessment of functional outcome in patients with head and neck cancer.Carotid artery infusion via implantable catheters for squamous cell carcinoma of the tonsils.
P2860
Q24235741-38E5AA30-179C-45FD-B774-AAFA5D215B7AQ26996504-ADBDFD75-E3DF-499D-98AE-9100DF1A70CDQ30499257-2496F0D7-EE06-4691-BD6C-E3A405F541D6Q33416289-6F96DEA9-01BA-4BAC-9739-342663E4EC45Q33886464-282ABA80-6240-4214-9FCB-38A1DC361795Q34142639-2DCE7963-ED31-4C16-BD72-2BB4F177C272Q34315600-D258C5ED-8A67-466A-963C-41E324637137Q34541908-886BA826-ABDA-4DB1-A779-ECAB2409801CQ35806678-81AC78AB-89F8-4A29-B8A2-90CB456F285CQ35978949-8D5FDAD2-BA1C-43B4-96AD-D20D92CF0508Q36067717-1BA29A07-957A-4B9C-A846-689E7735B463Q36206080-8214A07C-F062-4776-8178-00A0DAB99648Q36854151-D4FE55B3-4F4D-426D-83C0-348932709D5CQ37011791-D5B0EF3C-F1DD-4403-B70C-63957054FCD7Q37248886-610BEF8B-463A-4C1F-93D3-CBE6068DFA38Q37662274-EA05DF8E-6AD7-4EB3-AF75-AF027DC25768Q37812316-0006DFC7-A5F2-4F58-A471-18E25C098584Q38119441-B53D3BCD-D3C5-487F-BF76-F384FB27F949Q38176904-AE57D8B0-4D61-4DD4-BC00-D90CDF7B2FB2Q38197122-82E73EAF-3D8F-4B16-96CF-7A7C29D096F7Q38602875-604DCF76-27F9-46CF-AFBD-A7A4918E1B86Q38757864-A8A47399-409A-49B7-BA84-947CDD34823FQ38809582-6E1C4932-D7D4-493C-A0E2-3F68075B7658Q38936349-185AF64D-3024-4CA3-BF64-86DBC900E0CAQ38984523-30EF6634-1BE9-4559-9548-A6A0FB08C189Q39062518-DB927C35-893C-4C7B-80EE-F80650F40D58Q39791477-998953CF-AF88-4695-9855-D4653CC90F13Q40390118-027F0DB0-168C-4BDF-8C2B-8E36C99E68C9Q40465007-3FE226AF-81FF-47F9-B25C-BF962F295B53Q44431981-D15347D6-12C0-40C2-9C47-09E43C9C0FCCQ45378293-D9CDEAF8-A689-4D88-966A-CE950E729435Q46047278-743ED04B-8D00-480A-BFC9-7D5DFCE1C05DQ46425931-59C02204-C201-4EF4-B4BC-3805A02C71DAQ47641160-78751647-6815-4BE0-97D3-03F6CB078395Q48046907-F53BE774-B5CF-484E-9E4A-8FB4345B8AD6Q48485512-28DDAAAB-458B-40F2-B50E-6C74987A645EQ49968491-BD3BF790-48EE-407F-ACFD-B808E84AFEF2Q51005334-387CC821-ADC1-44FB-B85D-95B7C92B2E8CQ53159684-7D222917-C515-4BE1-8629-595369D0AF11Q55383819-E45388C7-E541-4F88-A41E-E898DCE72BF3
P2860
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
TAME: development of a new met ...... iation Therapy Oncology Group.
@en
type
label
TAME: development of a new met ...... iation Therapy Oncology Group.
@en
prefLabel
TAME: development of a new met ...... iation Therapy Oncology Group.
@en
P2093
P1433
P1476
TAME: development of a new met ...... iation Therapy Oncology Group.
@en
P2093
Adam S Garden
Andy Trotti
Arlene Forastiere
Clement K Gwede
Jay Cooper
John A Ridge
K Kian Ang
Rebecca Paulus
Thomas F Pajak
Wally Curran
P304
P356
10.1016/S1470-2045(07)70144-4
P577
2007-07-01T00:00:00Z